Page 48 - B Program News Today

Photo: Jeff Lagasse/Healthcare Finance News Six drugmakers who have violated the 340B statute should immediately begin offering drugs at discounted prices to hospitals participating in the federal drug-pricing program, according to a letter sent to the drugmakers this week from the Health Resources and Services  Administration. The HRSA maintained that the drug manufacturers in question – AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi and United Therapeutics – placed restrictions o...

University of Illinois at Chicago According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services — which are services that help remove barriers to accessing necessary medications — than comparably sized non-340B hospitals. The University of Illinois Chicago researchers who conducted the study, which included a survey of available services sent to a nationall...

6 days ago The Department of Health and Human Services (HHS) is seeking dismissal of a case brought by Sanofi-Aventis U.S. LLC challenging the requirements of a drug discount program for hospitals serving low-income patients — or, alternatively, the agency asked for summary judgment in its favor. The Sanofi suit is one of multiple disputes over an HHS advisory opinion that interpreted what is known as the 340B Program, which got its name from Section 340B of the Public Health Service Act. The...

AMORY – Through a memorandum of understanding with the City of Amory regarding the 340B plan, North Mississippi Medical Center Gilmore-Amory will use savings to help cover the cost of uncompensated and unreimbursed care for uninsured and low-income patients. The board of aldermen recently approved for Mayor Brad Blalock to sign the memorandum of understanding between the city and hospital. “Under our agreement, the hospital is making a commitment to continue to provide health care to ...

Maureen F. Kwiecinski is a health care lawyer with Foley & Lardner LLP, based in the firm’s Milwaukee office. Maureen counsels health systems, hospitals, medical clinics, blood centers, organ procurement organizations (OPOs) and other health care providers on corporate governance, strategic transactions, and significant investigations and corrective actions; as well as general

The ACCC 47 th Annual Meeting & Cancer Center Business Summit (AMCCBS) took place virtually, March 1-5. The Cancer Center Business Summit was co-founded in 2007 by Foley & Lardner LLP and CCBD Group as an opportunity for members of the community oncology c-suite, providers, vendors, payors, and others involved in the business of oncology to share best practices, learn about newest technologies, trends, and legal and business updates in the industry, and to strategize to position themselves for ...

Gov. Andrew Cuomo is under investigation amid sexual harassment allegations.

PolitiFacts ruling: Mostly False Heres why: A Republican running for U.S. Senate in North Carolina says Joe Biden is already raising drug prices for some of the most vulnerable Americans. Former Congressman Mark Walker hopes to replace U.S. Sen. Richard Burr, who won’t seek reelection next year. Two days after Biden’s inauguration, Walker took aim at the new Democratic president. "The disdain for President Trump and his accomplishments are so deep that President Biden is raising the prices ...

The Brownwood City Council on Tuesday, February 9, unanimously approved an ordinance on second and third/final reading for a request to change the zoning classification at  2409 Austin Avenue from R-1 Single-Family Residential District to R-3 Multifamily Residential District. At the Council meeting on Jan. 26, the Council heard protests to the zoning change from members of the public. Upon hearing from the residents and the developer, the Council voted to approve the zoning change on first rea...

Claims on social media and other outlets say the president overturned a Trump administration rule that would have lowered the cost of insulin.